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Abstract
Small proteins like amyloid beta (Aβ) monomers are related to neurodegenerative disorders
by aggregation to insoluble fibrils. Small angle neutron scattering (SANS) is a nondestruc-
tive method to observe the aggregation process in solution. We show that SANS is able to
resolve monomers of small molecular weight like Aβ for aggregation studies. We examine
Aβmonomers after prolonged storing in d-hexafluoroisopropanol (dHFIP) by using SANS
and dynamic light scattering (DLS). We determined the radius of gyration from SANS as
1.0±0.1 nm for Aβ1–40 and 1.6±0.1 nm for Aβ1–42 in agreement with 3D NMR structures in
similar solvents suggesting a solvent surface layer with 5% increased density. After initial
dissolution in dHFIP Aβ aggregates sediment with a major component of pure monomers
showing a hydrodynamic radius of 1.8±0.3 nm for Aβ1–40 and 3.2±0.4 nm for Aβ1–42 includ-
ing a surface layer of dHFIP solvent molecules.
Introduction
A common pathologic hallmark of neurodegenerative disorders like Alzheimer’s, Parkinson’s
or Huntington’s disease is the existence of amyloid deposits in the brain[1–6]. Amyloid is gen-
erated by abnormal protein aggregation leading to formation of insoluble protein fibrils with a
highly ordered cross-beta sheet structure. At the beginning of the 20th century beta amyloid
protein (Aβ) was supposed to be associated with Alzheimer disease (AD) in consequence of the
detection of Aβ fibril in intercellular plaques found in brain of AD patients[7]. Aβ fibrils and
soluble oligomers are suggested to be responsible for the disease symptoms, whereas the mono-
mers in the brain of AD patients are considered as nontoxic[8–10]. Aβ is a hydrophobic pro-
tein with 39–43 amino acid residues, which is produced by proteolytic cleavage of amyloid
precursor protein (APP) associated with the cell membrane[11]. The γ-secretase, within the
membrane region, generates the fibrillogenic C-terminus of Aβ[12] and may cause an amount
of isoforms dependent on the exact position for cleavage, where Aβ40 and Aβ42 are the most
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common, while the extracellular β-secretase cleaves N-terminally. The residues Leu17-Ala21
constitute the hydrophobic core of Aβ. The residues Lys28-Ala42 and Gly9-Ala21 are capable
to form α-helical or β-sheet structure, where the β-sheet is the priority for Lys28-Ala42[13,14].
As the key of AD investigation Aβmonomers have been studied by different methods as
nuclear magnetic resonance (NMR), analytical ultracentrifugation (AUC), circular dichroism
(CD) and Fourier transform infrared spectroscopy (FTIR)[15–18]. In aqueous environment
the monomeric Aβ is mainly unstructured[19], whereas apolar solvents induce a folded, α-heli-
cal structure[20,21]. The conformational change to β-sheet is supposed as the first step of the
aggregation process and has been observed by CD and NMR spectroscopy by increasing the
content of water in apolar solvents (hexafluoroisopropanol (HFIP), trifluoroethanol (TFE))
[17,22,23]. The classic hypothesis of fibril formation suggests monomer addition to soluble
oligomers or to the seeds for fibril formation, whereas current explorations propose firstly the
assembly of oligomers and secondly the structural conversion to β-sheet structure as alterna-
tive[16]. A nucleation like mechanism was used to explain the fibrillation in former studies
[24].
The fast conformational change with rapid onset of the aggregation process makes a study
of the early stage of aggregation from monomers to small oligomers and fibril formation in
aqueous solvents challenging. High-resolution structural methods fail to deliver the needed
information to understand disease mechanism, therefore low-resolution methods are impor-
tant to gain insight in structure and kinetics of the aggregation processes. Non-destructive
methods like dynamic light scattering (DLS) either give limited amount of information (only
hydrodynamic radius) or, like small angle X-ray scattering (SAXS) techniques, may have a
strong influence on the aggregation due to radiation damage associated with high intensity X-
ray sources. Methods like atomic force microscopy, analytical ultracentrifugation or transmis-
sion electron microscopy on the other hand give a snapshot of the aggregation process.
For all of the mentioned methods the preparation of the initial sample of Aβ is crucial as it
defines the starting point for examination of aggregation pathways. Different methods involv-
ing alkaline or acidic solutions or organic solvents are regularly used[25–28]. Solvents with
rich fluoride content as HFIP or TFE are known to produce stable amyloid protein monomer
solution and may lead to monomer dissociation from protofibrils/fibrils or break up of preag-
gregates[28–30]. After re-purification and before the addition of aqueous buffers the proteins
will be dried and consequently the protein concentration is much higher than in experiment
before the complete evaporation of HFIP.
Neutron scattering, in contrast to X-ray scattering, shows no radiation damage or radiation
induced aggregation even on delicate samples like unfolded proteins[31]. Small angle neutron
scattering (SANS) accesses the same low-resolution structural information as SAXS with a dif-
ferent scattering contrast as X-rays interact mainly with the electrons of the atoms and neu-
trons interact with the nucleus[32,33]. The scattered intensity depends on the isotopes
allowing contrast variation by isotope exchange[34] as e.g. using D2O instead of H2O to reduce
the scattering of the solvent. SAXS and SANS are frequently used to determine the low-resolu-
tion structure of proteins and protein complexes in solution[32,35]. By inelastic neutron scat-
tering methods the internal dynamics between domains on several nanosecond timescale or
the sidechain motions on picosecond timescales can be observed[36,37].
So far, SANS was rarely used to study aggregates and aggregation kinetics of small peptides
like Aβ or insulin, despite the advantage that it might reveal new structural information that is
not accessible by other methods and in contrast to SAXS does not induce radiation damage in
the sample[38–42]. Typically small angle scattering is used to determine the size or shape of
larger aggregates during aggregation. Discrimination between populations of monomers, small
oligomers and fibrils is challenging because of the low concentrations used in aggregation
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studies below 1 mg/ml and limited solubility of the peptides. Additionally discrimination is
only possible if clear differences between populations can be expected as in case of Aβ where
monomers, oligomers and large fibrils are present[43,44].
To examine the possibilities and limitations of small angle scattering techniques to observe
the monomer to oligomer transition exploiting the nondestructive character of neutrons as a
probe for delicate proteins, the monomer scattering is examined here as a limiting case for fur-
ther aggregation studies. In biological relevant environment (H2O or D2O buffers) the Aβ
monomer scattering is low and hardly to detect at lower concentrations as it is close to the
SANS instrument noise and the fast aggregation introduces aggregates/oligomers masking a
clear signal of the present monomers. Therefore we examined a monomeric solution in dHFIP
to show what can be expected from the scattering signal and which effects need to be included
in interpretation. This will help in the evaluation of aggregation studies by SANS to discrimi-
nate between monomers and oligomers. We examine here monomeric solutions of Aβ1–42 and
Aβ1–40 as the most common peptides for Aβ aggregation studies at relative high concentration
after incubation in dHFIP for several days. We observe a stable monomer population and a dis-
appearing aggregate population by DLS and examine the monomeric solution by SANS. We
demonstrate that SANS is capable to resolve monomeric Aβ with different radius of gyration
for Aβ1–42 and Aβ1–40 and strong indications for a solvent surface layer bound to the peptides.
Materials and Method
Materials
The Aβ peptide was purchased as TFA salt with>95% purity (Bachem, Weil am Rhein, Ger-
many). The deuterated 1,1,1,3,3,3-hexafluoro-2-propanol-D2 (dHFIP) was purchased from
euriso-top (Saint-Aubin, France) with>99% purity. Aβ was dissolved in dHFIP in the pur-
chased vials to yield a concentration of about 12 mg/ml dry mass including remaining salt or
interfacial water from the protein powder. The peptide concentration was determined by UV
absorption measurement (NanoDrop, Thermo Scientific, USA), applying an extinction coeffi-
cient at 280 nm of 1490 cm-1M-1, based on the single tyrosine residue of Aβ[45]. Final protein
concentrations were about 5.6 mg/ml for Aβ1–42 and about 2.4 mg/ml for Aβ1–40. No further
purification was done to prevent any additional decrease of concentration or material loss.
Incubation and all measurements for Aβ1–40 and Aβ1–42 were performed at 20°C. SANS experi-
ments were carried out after three weeks incubation in dHFIP.
Small Angle Neutron Scattering (SANS)
Experiments were performed at the high intensity SANS diffractometer KWS2 operated by
Jülich Center for Neutron Science at Heinz Maier Leibnitz Zentrum (MLZ) in Germany at a
wavelength λ = 4.7 Å with a wavelength spread of λ/Δλ = 0.2 [46]. The samples were measured
in 1 mm quartz cells (Hellma Analytics, Germany) at sample-detector-distances 1.1 m and 5.6
m covering the range of scattering vector Q = 4π/λsin(θ/2), with scattering angle θ, between
0.01 Å-1 and 0.5 Å-1. Samples and buffer measurements for background correction were mea-
sured for 1 h to 3 h dependent on detector distance. Appropriate standard methods for data
evaluation and background correction were used.
The coherent scattering intensity of particles in solution with background contributions bgr
is
IðQÞ ¼ N
V
SðQÞFðQÞ þ bgr ð1Þ
with the number of particles N in the volume V. Background bgr contributions are due to
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scattering from solvent and incoherent particle scattering. The interparticle interactions are
subsumed in the structure factor S(Q), which is for low concentrations equal one and is
neglected in the following. The scattering of the protein configuration is described by the form
factor F(Q).
FðQÞ ¼
X
i:j
hbibjexp ðiQðri  rjÞÞi ð2Þ
with the atomic position vectors ri and the atomic scattering lengths bi relative to the displaced
solvent scattering in the ensemble average<>[47]. The form factor is independent of the sam-
ple concentration and exhibits the particle shape, respectively the configuration. Additional
scattering from a surface layer of solvent around the protein can be taken into account by
assuming a layer of solvent with increased density compared to the bulk[47].
Models
The Beaucage function is a simple and common model being applied to analyze SANS data of
objects with undefined geometry. It describes the Guinier region at low Q with radius of gyra-
tion Rg as a measure of size and a power-law at high Q with dimensionality d as measure of
shape or configuration[48–50] as
FðQÞ ¼ Gexp Q
2R2g
3
 
þ C
Qd
 
erf
QRgffiffiffi
6
p
  3d
C ¼ Gd
Rdg
 !
6d2
ð2þ dÞð2þ 2dÞ
 d=2
Г
d
2
  ð3Þ
with the Guinier scaling factor G, the Porod scaling factor C, error function erf and Gamma
function Γ. With d = 2 it is a good approximate for the Gaussian coil[50].
Atomic modeling is based on the atom positions of PDB structures and Eq 2 taking into
account the scattering length difference relative to the solvent. To consider the excluded solvent
scattering the solvent excluded volume VSES needs to be determined. Therefore the protein sol-
vent accessible surface (SAS) is calculated with a probe radius Rp = 0.14 nm resulting in volume
VSAS and surface area ASAS as implemented in the used MMTK software[51,52]. As a fast
approximate for VSES we subtract the surface layer volume with a correction for overlapping
regions in grooves determined from the additional surface area with half the probe size as
VSES = VSAS-Rp×(ASAS(Rp)+0.5(ASAS(Rp)-ASAS(Rp/2)). The resulting specific volumes are
0.705 cm3/g and 0.720 cm3/g for Aβ1–40 and Aβ1–42 as average over the configurations in pdb
structures 1IYT and 1AML, respectively. Both values are slightly smaller compared to reported
values from analytical ultracentrifugation of 0.734 cm3/g and 0.738 cm3/g for Aβ1–40 and
Aβ1–42[18,53]. With these increased values for the specific volume the resulting scattering
would increase.
Dynamic Light Scattering (DLS)
Experiments were performed with a Zetasizer Nano ZS (Malvern Instruments, Worcestershire,
UK). The instrument uses a He-Ne laser with λ = 632.8 nm and vertical polarization in back-
scattering geometry at 173°. The sample cell is a UV-Cuvette micro (BRAND, Wertheim, Ger-
many) with 70 μl sample volume. To cover also larger aggregates (as the later third species) the
measurements duration was set to 1h to get reliable data at long times. The auto correlation
function was analyzed by non-negative least square (NNLS) algorithm[54] followed by protein
analysis (L-curve)[55] as implemented in the instrument software. The result is an intensity
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weighted distribution of hydrodynamic radius RH in the sense of a relaxation time distribution
where each relaxation time τ is interpreted via the Stoke-Einstein relation RH = kBT/6πηD with
the diffusion coefficient D = (Q2τ)-1 and Q as the scattering wave vector, Boltzmann constant
kB, temperature T and solution viscosity η. The mean RH and the width of the resulting distri-
bution characterize a population. It should be noted that the typical noise of the measured auto
correlation results in a distribution width of about 30% for an ideal monodisperse population.
The error of a mean RH is evaluated as standard deviation of repeated measurements. The vol-
ume fraction of a population can be evaluated from the volume-weighted distribution as calcu-
lated by the instrument software.
Results and Discussion
To examine the content of freshly in dHFIP dissolved Aβ powder we explored the evolution of
the intensity correlation of Aβ1–40 and Aβ1–42 in dHFIP at 20°C by repeated DLS experiment.
Shortly after dissolution three distinct particle populations can be observed (see Figs 1 and S1).
The population with largest RH belongs to peptide aggregates or fibrils (or contaminating dust
particles) with sizes larger than several microns. The remaining two populations show mean
relaxation times of about 20 μs and 5000 μs corresponding to hydrodynamic radii RH around 2
nm and 500 nm, which are clearly separated in the auto correlation function as shown in Fig 1.
The population with RH 2 nm and width typical for monomeric protein solutions refers to
monomers. Analysis of the volume weighted distributions shows that the monomer population
is the main component to the peptide content with more than 99% for all measurements.
Accordingly the concentration as measured by UV-Vis absorption does not change signifi-
cantly with time. The two larger populations refer to aggregates that strongly contribute to the
scattering intensity because the scattered intensity is proportional to the sixth power of the par-
ticle size. During the observation time the size of the second population varied between 100
nm and 3000 nm, where the content fluctuated, but mainly shows a decrease of the scattering
contribution. A change in size may be caused by monomer dissociation/aggregation from
aggregates, fragmentation/aggregation of aggregates or faster sedimentation of larger aggre-
gates. For the cases of dissociation, aggregation and fragmentation we expect an obvious
change of size including sizes smaller than 100 nm (relaxation times<1000 μs), which is not
observed in detectable amount. Therefore, we supposed that the dominating process for both
larger aggregate species is sedimentation during the incubation in dHFIP. Changes of the
aggregate contribution to the auto correlation may result from wobbling of the sample prior to
the measurement. After about 9 days incubation in dHFIP there is no more larger change in
the correlation function observable. The sample reached its equilibrium and contains hardly
any larger aggregates. The small particles have a hydrodynamic radius of about 1.8±0.3 nm for
Aß1-40 and 3.2±0.4 nm for Aß1-42.
Fig 2 shows the SANS scattering curves of Aβ in dHFIP. In spite of the relatively high con-
centrations—compared to aggregation studies with concentrations below 1 mg/ml—the inten-
sity is quite low due to the small size of Aβ and about a factor of 3 below the background of
pure dHFIP that is subtracted taking the protein volume fraction into account. A residual back-
ground at high Q is obvious, which is due to incoherent scattering from the protein (about
0.0025 cm-1 for the 5.6 mg/ml) and residual scattering from protonated water and salts in the
purchased protein powder. The difference in forward scattering of about a factor of 3 corre-
sponds mainly to the difference in concentration. Low intensity and residual background
favour together a Beaucage model including a background over the classical Guinier analysis
for Rg evaluation as the later does not include a background contribution[56]. The measured
intensity was modeled by a Beaucage function with fixed dimensionality (d = 2) within a least
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square fit including the residual background. The radius of gyration Rg evaluates to 1.6±0.1 nm
and 1.0±0.1 nm for Aβ1–42 and Aβ1–40 respectively (see Fig 2A).
The 3D structure of Aß1-42 monomer in dHFIP0.8D2O0.2 is available from the PDB data
bank (PDB code 1IYT) as measured by solution NMR (see Fig 3A) with a set of 10 conforma-
tions, which show mainly reorientations due to a small hinge between the two α-helices[20].
For Aβ1–40 a structure file (PDB code 1AML) measured in 40%TFE/water with 20 different
conformations is available (see Fig 3B)[21]. The simulated scattering curves of the conforma-
tions are illustrated in S3 Fig and the averages are shown in Fig 2B as broken line for both
structures. In both cases we find too strong scattering. Including the effect of a solvent surface
layer with higher density compared to the bulk solvent comparable to the hydration layer
observed for proteins in water[47] the calculated scattered intensity matches the measured
intensity with an increase in density of 5% for a 0.3 nm thick solvent surface layer. The surface
Fig 1. Time resolved DLS experiment of Aβ1–42 and Aβ1–40 in dHFIP. The samples were measured between 0.5 h and 14 days after initial incubation at
20°C. For Aβ1–40 the value of τ = 10000 μs is subtracted to focus on the two smaller species. For both samples correlations are normalized to 1 for τ!0 to get
a better overview over the data. Original measurements are found in S1 and S2 Figs.
doi:10.1371/journal.pone.0150267.g001
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layer in water seems to be mainly determined by geometric effects of the surface and partly by
the electrostatic field at the protein surface and water structure perturbation as shown by MD
simulations by Merzel and Smith[57]. At least a similar geometric effect of the protein surface
might be present here. MD simulations can only answer how far electrostatic effects or the
stronger hydrogen bonds of HFIP compared to water contribute. The mean Rg of Aβ1–42
monomer from these conformations is 1.58 nm and 1.46 nm including the surface layer (see S3
Fig). For Aβ1–40 the mean Rg is 1.29 nm and 1.16 nm including the surface layer. Thus a surface
layer with increased density decreases Rg as a result of the combination of solvent scattering
length density and protein scattering length density. The strong effect of the surface layer is
related to the large volume of the surface layer, which is in average a factor of 2.6 (1AML) and
2.3 (1IYT) larger than the protein volume. For a detailed determination of a changed density in
Fig 2. Scattering intensity of Aβmonomers in dHFIP (Aß1-42, concentration 5.6 mg/ml, Aß1-40 concentration 2.4 mg/ml) after three weeks
incubationmeasured at detector distance of 5.6 m (grey) and 1.1 m (black). (A) The red solid line shows the fitted Beaucage function with fixed
dimensionality d = 2. (B) SANS data compared to simulations based on atomic coordinates from 3D NMR structure data (Aß1-42 PDB code 1IYT, Aβ1–40
compared to PDB code 1AML). Broken blue lines represent the average over the PDB structures; while solid blue lines include a surface layer with increased
solvent density.
doi:10.1371/journal.pone.0150267.g002
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the surface layer a combination of SAXS and SANS with different contrast contributions is
required. SAXS measurements were not possible in dHFIP as the solvent evaporated due to the
high-energy input on a high intensity beam line. Nevertheless the observed radius of gyration
seems to be influenced by a solvent surface layer and shows compatibility of the observed
radius of gyration with previously reported structures of Aβ in similar solvents. It should be
noted that the actual configuration and flexibility has a strong influence on the scattering as
SANS measures the configurational ensemble. Comparing the simulated scattering of the dif-
ferent configurations according to the PDB structures (see S3 Fig) we observe that the Aβ1–42
scattering patterns stay quite similar as the small hinge between the two α-helices allows only
small changes of the configuration. Aβ1–40 has larger configurational freedom (more disor-
dered regions and stronger variation in the PDB structures) and consequently larger differ-
ences in the scattering patterns and Rg. Generally a larger configurational freedom may allow
more extended configuration. Nevertheless, the NMR structures and the SANS data show a
similar tendency with a more compact Aβ1–40 compared to Aβ1–42. The larger configurational
freedom results here in a more compact structure, which may be a result of a reduced contact
to the solvent.
The question arises how to compare the radius of gyration and the hydrodynamic radius as
both are influenced by a solvent surface layer, but in different ways. A simple approach for
globular proteins relates the radius RS of a sphere to the radius of gyration by R2g ¼ ð3=5ÞR2s
resulting in Rs of 2.06 nm for Aβ1–42 and 1.3 nm for Aβ1–40. If we assume that the monomer is
surrounded by a solvent layer contributing to the apparent hydrodynamic radius (2Rs,HFIP =
0.68 nm) the hydrodynamic radius of Aβ1–42 and Aβ1–40 monomer is about 2.7 nm and 2.0 nm
respectively, which correspond approximately to the measured RH from DLS experiment. In a
different approach based on measurements of Rg and RH for proteins between 50–400 residues
in denaturing solvents the relation Rg/RH = 1.06 is found[58]. Even taking into account that Aβ
is smaller than the reference proteins and the difference in solvent molecule size, too small
hydrodynamic radii result demonstrating that a Aβ seems to be not in a disordered state.
The hydrodynamic radii of Aβ1–42 and Aβ1–40 in water is according to Nag et al. 0.9 nm[43].
For both monomers the actual conformation in water is not known and the influence of a
hydration layer is undetermined. Assuming a hydration layer of 0.3 nm as found for other pro-
teins the configuration seems to be rather compact. Nevertheless it is clear that not only the
predominantly α-helical structure in dHFIP can increase the hydrodynamic radius as observed.
Fig 3. Exemplary structure of Aβmonomers: (a) Aβ1–42 dHFIP0.8D2O0.2 (PDB code 1IYT)[20] with two α
helices from residues Ser8-Gly25 and Lys28-Gly38, which is connected by a type I β-turn. (b) Aβ1–40 in
TFE0.4H2O0.6 (PDB code 1AML)[21] with two α helices from Gln15-Asp23 and from Ile31-Met35 connected
with a type I β-turn.
doi:10.1371/journal.pone.0150267.g003
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The strong hydrogen bonding properties of dHFIP may be of importance here. Stronger hydro-
gen bonding compared to the peptide in water may cause a larger peptide-solvent complex that
contributes to the hydrodynamic radius. For the smaller Aβ1–40 the more compact structure
reduces the surface to the solvent and a lower number of solvent molecules may contribute to
the complex resulting in the smaller hydrodynamic radius compared to Aβ1–42. The strong
hydrogen bonding of dHFIP allows solvation of monomeric peptides without aggregation for
Aβ and seems to increase the apparent hydrodynamic radius.
Conclusions
In this study we investigated the applicability of SANS to the study of the Alzheimer’s disease
associated amyloid beta peptide (Aβ). Several properties of this 4 to 5 kDa small peptide make
structural studies with high-resolution methods of the monomer as well as of the early assem-
bly states extremely difficult. Therefore, other methods giving less detailed structural informa-
tion become more important. Small angle neutron scattering and dynamic light scattering at
relatively high concentration (for Aβ aggregation experiments) was used to probe the applica-
tion of SANS as a scattering method without radiation damage for Aβ solutions as a prerequi-
site for further kinetic measurements of Aβ aggregation and fibril formation. We found that
the solvation of Aβ in dHFIP is a fast process, where after a short incubation of less than 1 h
the remaining aggregates mainly sediment. Therefore preparation time can be shortened by
centrifugation to sediment the small amount of aggregates. We showed that SANS is able to
perform measurements with monomeric Aβ solutions to determine the radius of gyration.
Although we cannot differentiate between conformations as in high-resolution techniques, we
find a more compact structure of Aβ1–40 compared to Aβ1–42 showing that low resolution
information can give valuable insight about the general structure. The difference in structure
between Aβ1–40 and Aβ1–42 regarding the distribution of α-helices and disordered regions
seems to be preserved in pure dHFIP. Additionally the results show the probable existence of a
surface layer with increased density of dHFIP solvent similar to the hydration layer of proteins
in water, which was not observed by other methods. The solvent surface layer increases the
hydrodynamic radius considerably. Still the application of SANS onto low concentration sam-
ples of a protein as small as Aβ would benefit from higher intensity and it is at the limit of the
nowadays possibilities.
Supporting Information
S1 Dataset. DLS and SANS data.
(ZIP)
S1 Fig. Time resolved DLS experiment with a concentration of 2.4 mg/ml Aβ1–40 in dHFIP.
The sample was measured between 0.5 h and 12 days after initial incubation at 20°C. The
strong change in the absolute value of the correlation function at τ! 0 (intercept) is due to the
increase in signal to noise ratio. With more large aggregates, respectively higher intensity, the
signal has less noise and the intercept is closer to one. Additionally the signal to noise ratio
depends on the laser attenuation chosen automatically by the instrument adjusting the mean
intensity to values between 200000 and 500000 counts/s dependent on the total scattered inten-
sity of a sample.
(EPS)
S2 Fig. DLS of 5.6 mg/ml Aβ1–42 in HFIP. The sample was measured between 0.5 h and 14
days after initial incubation at 20°C in HFIP. See S1 Fig for more comments.
(EPS)
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S3 Fig. Simulated scattering intensities for configurations according to PDB structures of
Aβ1–42 and Aβ1–40. Black and green lines take only the contrast to the dHFIP solvent into
account, while for red and blue lines additionally a solvent surface layer with 0.3 nm thickness
and 5% higher density compared to bulk dHFIP is used. The given radius of gyration Rg is the
average of the different structures in the PDB file as evaluated from the scattering in the Gui-
nier region. The differences in the forward scattering for the same protein arise due to the
changed protein volume if the configuration is changed.
(EPS)
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